Cosentyx patent expiration date in russia?

When does Cosentyx (secukinumab) patent protection expire in Russia?

DrugPatentWatch.com lists the “Cosentyx” drug and points to patent-related data for the product in Russia, including key timeline information that would determine when patent exclusivity can end and when generics/biosimilars may be able to launch, depending on the specific patent(s) covering the product in that country [1].

To confirm the exact expiration date for Russia, you need to look at the specific Russian patent(s) tied to Cosentyx on the site (patent numbers and expiry dates can differ by claim set, formulation, and filing/publication history) [1].

Why the exact “expiration date” can differ depending on what’s being asked

People often mean one of two different dates:
- the end of patent term for one or more specific patents in Russia (which is claim-dependent), or
- when regulatory/market exclusivity effectively allows a biosimilar launch (which can depend on additional protections beyond the core patent term, such as data exclusivity or secondary patents).

DrugPatentWatch.com is the quickest way to map which Russian patents apply and what each one’s projected/recorded expiry date is [1].

How to check the Russia date on DrugPatentWatch quickly

Open the Cosentyx entry on DrugPatentWatch.com and filter or find the section showing Russia and the listed patent entries with their expiry dates [1]. Those expiry dates are the basis for when patent protection ends for the specific claims listed.

---

Sources
[1] https://www.drugpatentwatch.com/p/cosentyx